INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,291,603 | -73.9% | 187,945 | -76.8% | 0.00% | -77.8% |
| Q2 2023 | $47,079,969 | +59.0% | 809,769 | +68.9% | 0.01% | +50.0% |
| Q1 2023 | $29,602,663 | -17.1% | 479,473 | -14.7% | 0.01% | -25.0% |
| Q4 2022 | $35,707,118 | +11.1% | 561,786 | +27.0% | 0.01% | +14.3% |
| Q3 2022 | $32,143,000 | +53.2% | 442,506 | +43.4% | 0.01% | +40.0% |
| Q2 2022 | $20,980,000 | -26.3% | 308,578 | -1.8% | 0.01% | -16.7% |
| Q1 2022 | $28,477,000 | +88.4% | 314,180 | +89.7% | 0.01% | +100.0% |
| Q4 2021 | $15,115,000 | +221.3% | 165,605 | +185.5% | 0.00% | +200.0% |
| Q3 2021 | $4,704,000 | -16.9% | 58,012 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $5,662,000 | +90.8% | 60,695 | +118.8% | 0.00% | 0.0% |
| Q1 2021 | $2,968,000 | -19.9% | 27,743 | -34.6% | 0.00% | 0.0% |
| Q4 2020 | $3,705,000 | +83.0% | 42,443 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $2,025,000 | – | 41,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |